Inactive Instrument

Insiders Cyxone AB (publ) Nasdaq Stockholm

Equities

Sweden's Cyxone Appoints New CEO	22/04	MT
Cyxone AB Announces Chief Executive Officer Changes	22/04	CI
Cyxone AB Announces Board Changes	30/23/30	CI
Cyxone AB Announces Board Resignations	26/23/26	CI
Cyxone Confirms Acting CEO with Permanent Appointment	13/22/13	MT
Cyxone AB Appoints Carl-Magnus Högerkorp as Permanent CEO	13/22/13	CI
Cyxone AB Announces That the Members of the Nomination Committee for Annual General Meeting 2023	08/22/08	CI
Cyxone Appoints Erika Samuelsson as Chief Development Officer	22/22/22	CI
Biotech Company Cyxone Appoints New Chief Development Officer	02/22/02	MT
Cyxone AB Appoints Erika Samuelsson as Chief Development Officer	02/22/02	CI
Swedish Drugmaker Cyxone CEO Departs	21/22/21	MT
Cyxone Announces Executive Changes	20/22/20	CI
Cyxone : Instruction and charter for the Nomination Committee	12/22/12	PU
Swedish Biotech Firm Cyxone's Chief Medical Officer Exits	23/22/23	MT
Cyxone Announces Resignation of Cornel Pater as Chief Medical Officer	23/22/23	CI
Cyxone AB Appoints Cornel Pater as New Chief Medical Officer	01/21/01	CI
Cyxone AB Appoints Ola Skanung as Senior Executive Advisor	09/21/09	CI
Cyxone AB Elects Peter Heinrich and Alejandra Mørk as New Board Members	03/21/03	CI
Cyxone AB Announces Executive Changes	25/21/25	CI
Christin Arrhenius Bokedal to Join Cyxone AB as Head of Development	08/20/08	CI

No results for this search